Related Experiment Video

Updated: Aug 4, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Pulmonary metastases from a chromophobe renal cell carcinoma: 10 years' evolution

C Badoual, F Tissier, C Lagorce-Pages

    Histopathology
    |March 16, 2002
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
    05:36

    Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

    Published on: February 8, 2020

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
    11:17

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

    Published on: February 27, 2026

    Related Experiment Videos

    Last Updated: Aug 4, 2026

    A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
    06:38

    A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

    Published on: April 12, 2017

    Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
    05:36

    Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

    Published on: February 8, 2020

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
    11:17

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

    Published on: February 27, 2026

    Related Concept Videos

    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

    Articles linked to this work by shared authors, journal, and citation graph.

    Neoadjuvant immunotherapy for nonmetastatic dMMR/MSI colon cancer: a real-world retrospective AGEO study.

    ESMO open·2025

    Prognostic Significance of the Microenvironment in Human Papillomavirus Oropharyngeal Carcinoma: A Systematic Review.

    The Laryngoscope·2023

    Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy Setting.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2022

    Evaluation of robotic surgery for transoral resection of T1-2 squamous cell carcinoma of the tonsillar fossa.

    European annals of otorhinolaryngology, head and neck diseases·2019

    [Multidisciplinary consultation for patients with HPV-related invasive carcinoma or precancerous lesions].

    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2018

    Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018

    MET expression by immunohistochemistry as a biomarker in pancreatic neuroendocrine tumours.

    Histopathology·2026

    Cutaneous lymphomas - an update.

    Histopathology·2026

    AI-based segmentation of occult cervical lymph node metastases: potential reduction of cytokeratin staining.

    Histopathology·2026

    Histological manifestations of vitamin A toxicity in the liver.

    Histopathology·2026

    Plexiform Wagner-Meissner schwannoma with a SH3PXD2A::HTRA1 fusion: a twisted sister?

    Histopathology·2026

    Cutaneous involvement by myeloid leukaemias: challenging cases with important implications.

    Histopathology·2026

    Pancreatic ductal adenocarcinomas arising from intraductal papillary mucinous neoplasms are aggressive despite being low stage: implications on screening and "early diagnosis".

    Virchows Archiv : an international journal of pathology·2026

    Evaluation of grading systems among pulmonary adenocarcinomas: architectural grade combined with STAS is superior to others - a single centre study.

    Virchows Archiv : an international journal of pathology·2026

    Outcome-Adaptive Lasso for Cox Proportional Hazards Model.

    Biometrical journal. Biometrische Zeitschrift·2026

    Neoatherosclerosis after coronary stenting: mechanisms, diagnosis, and treatment.

    European heart journal·2026

    Relationship Between Number of Acute Pancreatitis Episodes and Risk of New-onset Diabetes in the U.S.: A Real-world Data Analysis.

    Pancreas·2026

    Mechanosensitive phosphorylation of NFATC4 at S213/S217 drives fibroblast-to-myofibroblast transition and fibrosis.

    The Journal of clinical investigation·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us